6 November 2023, London – Qinecsa Solutions, specialists in technology-led end-to-end pharmacovigilance solutions, today announced the appointment of Arthur Shih as General Counsel. With over 25 years in private practice and in-house leadership roles, Arthur brings extensive international legal and commercial experience to support the execution of Qinecsa’s future growth strategy.
“Qinecsa is a market-leader in pharmacovigilance services and technology with strong customer relationships and an impressive track-record of innovation,” said Arthur Shih. “I am privileged to be joining such an organization and look forward to helping to further grow the business.”
“Arthur has an impressive background providing strategic leadership and direction in private equity backed companies,” commented John Gillie, CEO of Qinecsa Solutions. “His experience across legal affairs, M&A, regulatory, and risk management, including development of associated compliance programs, will play a critical role in the next phase of Qinecsa’s growth.”
About Qinecsa Solutions
Qinecsa specializes in technology-led end-to-end pharmacovigilance solutions. We are trusted, global partners bringing together best-in-class technology and scientific expertise to connect life science companies to the right safety solutions. Through our unique insight into the challenges of pharmacovigilance, we have created industry-leading, end-to-end solutions for capturing, managing, and evaluating drug safety data, more efficiently and accurately. Working with life science companies we drive progress to continue protecting lives.
